Bijesh Kumar Biswal

1.3k total citations
49 papers, 966 citations indexed

About

Bijesh Kumar Biswal is a scholar working on Molecular Biology, Toxicology and Cancer Research. According to data from OpenAlex, Bijesh Kumar Biswal has authored 49 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 9 papers in Toxicology and 8 papers in Cancer Research. Recurrent topics in Bijesh Kumar Biswal's work include Bioactive Compounds and Antitumor Agents (9 papers), MicroRNA in disease regulation (7 papers) and Cancer therapeutics and mechanisms (7 papers). Bijesh Kumar Biswal is often cited by papers focused on Bioactive Compounds and Antitumor Agents (9 papers), MicroRNA in disease regulation (7 papers) and Cancer therapeutics and mechanisms (7 papers). Bijesh Kumar Biswal collaborates with scholars based in India, United States and South Korea. Bijesh Kumar Biswal's co-authors include Surya Kant Tripathi, Munmun Panda, Kannan R. R. Rengasamy, Rama Shanker Verma, Kamal Pandey, Michael J. Spinella, Gökhan Zengin, Niladri Bihari Debata, Sugapriya Dhanasekaran and Venil N. Sumantran and has published in prestigious journals such as PLoS ONE, Cancer Research and Archives of Biochemistry and Biophysics.

In The Last Decade

Bijesh Kumar Biswal

45 papers receiving 951 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bijesh Kumar Biswal India	18	541	162	150	144	140	49	966
Surya Kant Tripathi India	15	374 0.7×	144 0.9×	137 0.9×	101 0.7×	122 0.9×	34	784
Purusottam Mohapatra India	21	780 1.4×	419 2.6×	96 0.6×	142 1.0×	274 2.0×	39	1.5k
Peng Zou China	27	1.1k 2.1×	226 1.4×	63 0.4×	396 2.8×	180 1.3×	58	1.8k
Alexander M. Scherbakov Russia	19	633 1.2×	327 2.0×	95 0.6×	208 1.4×	201 1.4×	118	1.1k
Sha Zeng China	17	653 1.2×	55 0.3×	67 0.4×	280 1.9×	285 2.0×	32	1.2k
Shakti Ranjan Satapathy India	22	606 1.1×	183 1.1×	49 0.3×	141 1.0×	285 2.0×	45	1.2k
Xuejiao Song China	19	508 0.9×	150 0.9×	39 0.3×	122 0.8×	219 1.6×	37	943
Ranjan Preet India	19	868 1.6×	399 2.5×	86 0.6×	227 1.6×	248 1.8×	28	1.4k
Chengguang Zhao China	25	1.0k 1.9×	258 1.6×	140 0.9×	281 2.0×	500 3.6×	47	1.9k
Chong Ock Lee South Korea	21	773 1.4×	310 1.9×	66 0.4×	75 0.5×	303 2.2×	53	1.3k

Countries citing papers authored by Bijesh Kumar Biswal

Since Specialization

Citations

This map shows the geographic impact of Bijesh Kumar Biswal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bijesh Kumar Biswal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bijesh Kumar Biswal more than expected).

Fields of papers citing papers by Bijesh Kumar Biswal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bijesh Kumar Biswal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bijesh Kumar Biswal. The network helps show where Bijesh Kumar Biswal may publish in the future.

Co-authorship network of co-authors of Bijesh Kumar Biswal

This figure shows the co-authorship network connecting the top 25 collaborators of Bijesh Kumar Biswal. A scholar is included among the top collaborators of Bijesh Kumar Biswal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bijesh Kumar Biswal. Bijesh Kumar Biswal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pradhan, Arun Kumar, Bijesh Kumar Biswal, Chanakya Nath Kundu, et al.. (2025). Amphiphilic Poly(ethylene glycol)-Cholesterol Conjugate: Stable Micellar Formulation for Efficient Loading and Effective Intracellular Delivery of Curcumin. ACS Applied Bio Materials. 8(2). 1418–1436. 5 indexed citations

Mallick, Bibekanand, et al.. (2025). PLK1 inhibition by Shikonin attenuates oral cancer growth through β-catenin-mediated regulation of EMT and apoptosis. Cellular Signalling. 138. 112262–112262.

Ansari, Zahid, et al.. (2025). Integrative computational and experimental validation of Piperlongumine as a therapeutic agent targeting differentially expressed genes in colorectal cancer. Pathology - Research and Practice. 275. 156243–156243.

Biswal, Bijesh Kumar, et al.. (2024). Enigmatic exosomal connection in lung cancer drug resistance. Molecular Therapy — Nucleic Acids. 35(2). 102177–102177. 8 indexed citations

Panda, Munmun, et al.. (2024). Shikonin Stimulates Mitochondria‐Mediated Apoptosis by Enhancing Intracellular Reactive Oxygen Species Production and DNA Damage in Oral Cancer Cells. Journal of Cellular Biochemistry. 126(1). e30671–e30671. 7 indexed citations

Tripathi, Surya Kant, et al.. (2024). Exposure of piperlongumine attenuates stemness and epithelial to mesenchymal transition phenotype with more potent anti-metastatic activity in SOX9 deficient human lung cancer cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(8). 5631–5647. 4 indexed citations

Biswal, Bijesh Kumar, et al.. (2024). The phytochemical plumbagin: mechanism behind its “pleiotropic” nature and potential as an anticancer treatment. Archives of Toxicology. 98(11). 3585–3601. 1 indexed citations

Biswal, Bijesh Kumar, et al.. (2024). Molecular insights to therapeutic in cancer: role of exosomes in tumor microenvironment, metastatic progression and drug resistance. Drug Discovery Today. 29(8). 104061–104061. 15 indexed citations

Panda, Munmun, et al.. (2023). Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer. Archives of Oral Biology. 151. 105697–105697. 13 indexed citations

10.

Tripathi, Surya Kant, et al.. (2022). SOX9 as an emerging target for anticancer drugs and a prognostic biomarker for cancer drug resistance. Drug Discovery Today. 27(9). 2541–2550. 17 indexed citations

11.

Gupta, Piyush Kumar, Surya Kant Tripathi, Rekha Gahtori, et al.. (2021). Anticancer therapeutic efficacy of biogenic Am-ZnO nanoparticles on 2D and 3D tumor models. Materials Today Chemistry. 22. 100618–100618. 40 indexed citations

12.

Tripathi, Surya Kant & Bijesh Kumar Biswal. (2021). Allosteric mutant-selective fourth-generation EGFR inhibitors as an efficient combination therapeutic in the treatment of non-small cell lung carcinoma. Drug Discovery Today. 26(6). 1466–1472. 26 indexed citations

13.

Pandey, Kamal, Surya Kant Tripathi, Munmun Panda, & Bijesh Kumar Biswal. (2020). Prooxidative activity of plumbagin induces apoptosis in human pancreatic ductal adenocarcinoma cells via intrinsic apoptotic pathway. Toxicology in Vitro. 65. 104788–104788. 22 indexed citations

14.

Tripathi, Surya Kant & Bijesh Kumar Biswal. (2020). Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent. Pharmacological Research. 156. 104772–104772. 108 indexed citations

15.

Tripathi, Surya Kant, Munmun Panda, & Bijesh Kumar Biswal. (2019). Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food and Chemical Toxicology. 125. 566–582. 103 indexed citations

16.

Tripathi, Surya Kant & Bijesh Kumar Biswal. (2018). Pterospermum acerifolium (L.) wild bark extract induces anticarcinogenic effect in human cancer cells through mitochondrial-mediated ROS generation. Molecular Biology Reports. 45(6). 2283–2294. 13 indexed citations

17.

Mao, Pingping, Gilbert J. Rahme, Eric C. Yang, et al.. (2013). Serine/Threonine Kinase 17A Is a Novel Candidate for Therapeutic Targeting in Glioblastoma. PLoS ONE. 8(11). e81803–e81803. 26 indexed citations

18.

Dhanasekaran, Sugapriya, Bijesh Kumar Biswal, Venil N. Sumantran, & Rama Shanker Verma. (2013). Augmented sensitivity to methotrexate by curcumin induced overexpression of folate receptor in KG-1 cells. Biochimie. 95(8). 1567–1573. 26 indexed citations

19.

Biswal, Bijesh Kumar, et al.. (2009). Tumor cell imaging using the intrinsic emission from PAMAM dendrimer: a case study with HeLa cells. Cytotechnology. 61(1-2). 17–24. 14 indexed citations

20.

Biswal, Bijesh Kumar & Rama Shanker Verma. (2009). Differential Usage of the Transport Systems for Folic acid and Methotrexate in Normal Human T-Lymphocytes and Leukemic Cells. The Journal of Biochemistry. 146(5). 693–703. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact